At a glance
- Originator Research Biochemicals
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Adenosine A1 receptor agonists; Glycolysis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 03 Sep 1998 No-Development-Reported for Ischaemic heart disorders in Canada (Unknown route)
- 05 Aug 1996 New profile
- 05 Aug 1996 Preclinical development for Ischaemic heart disorders in Canada (Unknown route)